Nutridynamics - studying the dynamics of food components in products and in the consumer

Current Opinion in Biotechnology

Volumn 17, Issue 2, 2006, Pages 217-225

  de Vos, Willem M ^a,b   Castenmiller, Jacqueline JM ^a   Hamer, Rob J ^a   Brummer, Robert Jan M ^a  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CONSUMER PRODUCTS; DIGESTIVE SYSTEM; METABOLISM; NUTRITION;

BIOACTIVE INGREDIENTS; FOOD MATRIX; MECHANISTIC EFFECTS; NUTRIDYNAMICS;

FOOD PRODUCTS;

CARBOHYDRATE; FOLIC ACID; GLUCOSE; PROBIOTIC AGENT;

BACTERIAL STRAIN; BIOAVAILABILITY; CARBOHYDRATE INTAKE; CONSUMER; DAIRY PRODUCT; DNA MODIFICATION; FOOD BIOTECHNOLOGY; FOOD INDUSTRY; FOOD PROCESSING; FOOD QUALITY; GLUCOSE BLOOD LEVEL; GLYCEMIC LOAD; LACTIC ACID BACTERIUM; LACTOBACILLUS ACIDOPHILUS; NUTRIENT DYNAMICS; NUTRIGENOMICS; PRIORITY JOURNAL; REVIEW;

EATING; FOOD MICROBIOLOGY; FOOD SUPPLY; HUMANS; NUTRITION PHYSIOLOGY;

EID: 33645914440     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2006.02.008     Document Type: Review

References (74)

1. Anonymous: The World Market on Functional Foods and Beverages; 2004. Euromonitor International. URL: http://www.euromonitor.com.
2. St-Onge M.P., and Jones P.J. Phytosterols and human lipid metabolis: efficacy, safety and novel foods. Lipids 38 (2003) 367-375
3. Dietrich M., Brown C.J., and Block G. The effect of folate fortification of cereal-grain products in blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr 24 (2005) 266-274
4. Saxelin M., Tynkkynen S., Mattila-Sandholm T., and de Vos W.M. Probiotic and other functional microbes: from markets to mechanism. Curr Opin Biotechnol 16 (2005) 204-211
5. Jobling S. Improving starch for food and industrial applications. Curr Opin Plant Biol 7 (2004) 210-218
6. Dhiman T.R., Nam S.H., and Ure A. Factors affecting conjugated linoleic acid content in milk and meat. Crit Rev Food Sci Nutr 45 (2005) 463-482
7. Abdel-Rahman S.M., and Kauffman R.E. The integration of pharmacokinetics and pharmacodynamics: understanding dose-response. Annu Rev Pharmacol Toxicol 44 (2004) 111-136
8. de Vos W.M., Bron P.A., and Kleerebezem M. Post-genomics of lactic acid bacteria and other food-grade bacteria to discover gut functionality. Curr Opin Biotechnol 15 (2004) 86-93
9. Saris W. Sugars, energy metabolism, and body weight control. Am J Clin Nutr 78 (2003) 850S-857S
10. McAuley K.A., Smith K.J., Taylor R.W., McLay R.T., Williams S.M., and Mann J.I. Long-term effects of popular dietary approaches on weight loss and features of insulin resistance. Int J Obes 30 (2006) 342-349
11. Hensrud D.D. Diet and obesity. Curr Opin Gastroenterol 20 (2004) 119-124
12. Riccardi G., Capaldo B., and Vaccaro O. Functional foods in the management of obesity and type 2 diabetes. Curr Opin Nutr Metab Care 8 (2005) 630-635
13. Englyst K.N., and Englyst H.N. Carbohydrate bioavailability. Br J Nutr 94 (2005) 1-11. A rational basis is provided for the nutritional characterisation of dietary carbohydrates. A classification and measurement scheme is proposed based on the properties of carbohydrate foods identified to be of specific relevance to health. This is complementary to the dietary fibre and glycaemic index concepts in the promotion of healthy diets with low energy density required for combating obesity-related diseases.
14. Manning T.S., and Gibson G. Microbial-gut interactions in health and disease. Prebiotics Best Prac Res Clin Gastroenterol 18 (2004) 287-298
15. Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., and Gordon J.I. Obesity alters microbial gut ecology. Proc Natl Acad Sci USA 102 (2005) 11070-11075. Using 16S rDNA-based approaches, the composition was determined of the distal intestinal (cecal) microbiota of genetically obese ob/ob mice, lean ob/+ and wild-type siblings, and their ob/+ mothers, all fed the same polysaccharide-rich diet. Compared with lean mice and regardless of kinship, ob/ob animals have a 50% reduction in the abundance of Bacteroidetes and a proportional increase in Firmicutes. These first results on the relation between obesity and the diversity of the gut microbiota suggest that intentional manipulation of community structure might be useful for regulating energy balance in obese individuals.
16. Livesey G. Low glycaemic diets and health: implications for obesity. Proc Nutr Soc 64 (2005) 105-113
17. Raatz S.K., Torkelson C.J., Redmon J.B., Reck K.P., Kwong C.A., Swanson J.E., Liu C., Thomas W., and Bantle J.P. Reduced glycemic index and glycemic load diets do not increase the effects of energy restriction on weight loss and insulin sensitivity in obese men and women. J Nutr 135 (2005) 2387-2391
18. Pardridge W.M. Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids. Neurochem Res 23 (1998) 635-644
19. Banks W.A. The source of cerebral insulin. Eur J Pharmacol 490 (2004) 5-12
20. Kilkens T.O., Honig A., van Nieuwenhoven M.A., Riedel W.J., and Brummer R.J. Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls. Gut 53 (2004) 1794-1800
21. Monro J. Expressing the glycaemic potency of foods. Proc Nutr Soc 64 (2005) 115-122. A new indicator, the glycemic glucose equivalent (GGE), is introduced that overcomes the limitations of GI. It is defined as the weight of glucose that would induce a glycemic response equal to that induced by the food. It is concluded that the GGE is also a scientifically more precise and meaningful term with which to express glycaemic potency than is GL.
22. Brouns F., Kettlitz B., and Arrigoni E. Resistant starch and the butyrate revolution. Trends Food Sci Technol 13 (2002) 251-261
23. Egert M., de Graaf A.A., Smidt H., de Vos W.M., and Venema K. Beyond diversity - functional microbiomics for the human colon. Trends Microbiol 14 (2006) 86-91
24. Leinonen K., Liukkonen K., Poutanen K., Uusitupa M., and Mykkanen H. Rye bread decreases postprandial insulin response but does not alter glucose response in healthy Finnish subjects. Eur J Clin Nutr 53 (1999) 262-267
25. Juntunen K.S., Laaksonen D.E., Autio K., Niskanen L.K., Holst J.J., Savolainen K.F., Liokkonen K.H., Poutanen K.S., and Mykkanen H.M. Structural differences between rye and wheat bread but not total fiber content may explain the lower postprandial insulin response to rye bread. Am J Clin Nutr 78 (2003) 957-964
26. Laaksonen D.E., Toppinen L.K., Juntunen K.S., Autio K., Liukkonen K.H., Poutanen K.S., Niskanen L., and Mykkanen H.M. Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome. Am J Clin Nutr 82 (2005) 1218-1227. This and other studies of this group have addressed the potential benefits of rye bread in a systematic way and conclude that bread and pasta-based carbohydrate modification enhances early insulin secretion in persons with the metabolic syndrome. This may lower the risk of deteriorating glucose tolerance and development of type 2 diabetes.
27. Garcia-Alonso A., and Goni I. Effect of processing on potato starch: in vitro availability and glycaemic index. Nahrung 44 (2000) 19-22
28. Seal J., Daly M.E., Thomas L.C., Bal W., Birkett A.M., Jeffcoat R., and Mathers J.C. Postprandial carbohydrate metabolism in healthy subjects and those with type 2 diabetes fed starches with slow and rapid hydrolysis rates determined in vitro. Br J Nutr 90 (2003) 853-864
29. Garsetti M., Vinov S., Lang V., Holt S., Lover S., and Brand-Miller J.C. The glycemic and insulinemic index of plain sweet biscuits: relationship to in vitro starch digestibility. J Am Coll Nutr 24 (2005) 441-447
30. Torsdottir I., Alpsten M., Andersson D., Brummer R.J., and Andersson H. Effect of different starchy foods in composite meals on gastric emptying rate and glucose metabolism. I. Comparisons between potatoes, rice and white beans. Hum Nutr Clin Nutr 38 (1984) 329-338
31. Jonston C.S., and Buller A.J. Vinegar and peanut products as complementary foods to reduce postprandial glycemia. J Am Diet Assoc 105 (2005) 1939-1942
32. Ostman E., Granfeldt Y., Persson L., and Bjorck I. Vinegar supplementation lowers glucose and insulin responses and increases satiety after a bread meal in healthy subjects. Eur J Clin Nutr 59 (2005) 983-988
33. Ramos M.I., Allen L.H., Dungas D.M., Jagust W.J., Haan M.N., Green R., and Miller J.W. Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on aging. Am J Clin Nutr 82 (2005) 1346-1352
34. Durga J., van Boxtel M.P., Schouten E.G., Bots M.L., Kok F.J., and Verhoef P. Folate and the methylene tetrahydrofolate reductase 677C>T mutation correlate with cognitive performance. Neurobiol Aging 27 (2006) 334-343
35. Verhoef P., Sampfer M.J., and Rimm E.B. Folate and coronary heart disease. Curr Opin Lipodol 9 (1998) 17-22
36. Melse-Boonstra A., West C.E., Katan M.B., Kok F.J., and Verhoef P. Bioavailability of heptaglutamyl relative to monoglutamyl folic acid in healthy adults. Am J Clin Nutr 79 (2004) 424-429
37. Hannon-Fletcher M.P., Armstrong N.C., Scott J.M., Pentieva K., Bradbury I., Ward M., Strain J.J., Dunn A.A., Molloy A.M., Kerr M.A., and McNulty H. Determining bioavailability of food folates in a controlled intervention study. Am J Clin Nutr 80 (2004) 911-918
38. Konings E.J., Troost F.J., Castenmiller J.J., Roomans H.H., van den Brandt P.A., and Saris W. Intestinal absorption of different types of folate in healthy subjects with an ileostomy. Br J Nutr 88 (2002) 235-242
39. Melse-Boonstra A., Lievers K.J., Blom H.J., and Verhoef P. Bioavailability of polyglutamyl folic acid relative to that of monoglutamyl folic acid in subjects with different genotypes of the glutamate carboxypeptidase II gene. Am J Clin Nutr 80 (2004) 700-704
40. McNulty H., and Pentieva K. Folate bioavailability. Proc Nutr Soc 63 (2004) 529-536
41. Melse-Boonstra A., Verhoef P., and West C.E. Quantifying folate bioavailability: a critical appraisal of methods. Curr Opin Clin Nutr Metab Care 7 (2004) 539-545
42. Finglas P.M., de Meer K., Molloy A., Verhoef P., Pietrzik K., Powers H.J., van der Straeten D., Jagerstad M., Varela-Moreiras G., van Vliet T., et al. Research goals for folate and related B vitamin in Europe. Eur J Clin Nutr 60 (2006) 287-294. Provides a comprehensive overview of the understanding of folate bioavailability, metabolism and related health issues. Avenues for future research are recommended, including various aspects of the nutridynamics concept, that are relevant for progress at the scientific, industrial and legislative level.
43. Picciano M.F., West S.G., Ruch A.L., Kris-Etherton P.M., Zhao G., Johnston K.E., Maddox D.H., Fishell V.K., Dirienzo D.B., and Tamura T. Effect of cow milk on food folate bioavailability in young women. Am J Clin Nutr 80 (2004) 1565-1569
44. Jones M.L., Treloar T., and Nixon P.F. Dietary interactions influence the effects of bovine folate-binding protein on the bioavailability of tetrahydrofolates in rats. J Nutr 133 (2003) 489-495
45. de Jong R.J., Verwei M., West C.E., van Vliet T., Siebelink E., van den Berg H., and Castenmiller J.J. Bioavailability of folic acid from fortified pasteurised and UHT-treated milk in humans. Eur J Clin Nutr 59 (2005) 906-913
46. Crittenden R.G., Martinez N.R., and Playne M.J. Synthesis and utilization of folate by yoghurt starter cultures and probiotic bacteria. Int J Food Microbiol 80 (2003) 217-222
47. Sybesma W., Starrenburg M., Kleerebezem M., Mierau I., de Vos W.M., and Hugenholtz J. Increased production of folate by metabolic engineering of Lactococcus lactis. Appl Environ Microbiol 69 (2003) 3069-3076
48. Sybesma W., van den Born E., Starrenburg M., Mierau I., Kleerebezem M., de Vos W.M., and Hugenholtz J. Controlled modulation of folate polyglutamyl tail length by metabolic engineering of Lactococcus lactis. Appl Environ Microbiol 69 (2003) 7101-7107
49. Klaenhammer T.R., Barrangou R., Buck B.L., Azcarate-Peril M.A., and Altermann E. Genomic features of lactic acid bacteria effecting bioprocessing and health. FEMS Microbiol Rev 29 (2005) 393-409. This timely review addresses the genome revolution that is driving a plethora of possibilities related to the use of lactic acid and probiotic bacteria.
50. Marco M, Pavan S, Kleerebezem M: Towards molecular understanding of probiotic mode of action. Curr Opin Biotechnol 2006: in press.
51. Prakash S., and Martoni C. Toward a new generation of therapeutics: artificial cell targeted delivery of live cells for therapy. Appl Biochem Biotechnol 128 (2006) 1-22
52. Ananta E., and Knorr D. Evidence on the role of protein biosynthesis in the induction of heat tolerance of Lactobacillus rhamnosus GG by pressure pre-treatment. Int J Food Microbiol 15 (2004) 307-313
53. Daly M.J., Gaidamakova E.K., Matrosova V.Y., Vasilenko A., Zhai M., Venkateswaran A., Hess M., Omelchenko M.V., Kostandarithes H.M., Wackett L.P., et al. Accumulation of Mn(II) in Deinococcus radiodurans facilitates γ-radiation resistance. Science 306 (2004) 1025-1028
54. Groot M.N., Klaassens E., de Vos W.M., Delcour J., Hols P., and Kleerebezem M. Genome-based in silico detection of putative manganese transport systems in Lactobacillus plantarum and their genetic analysis. Microbiol 151 (2005) 1229-1238
55. Saarela M., Rantala M., Hallamaa K., Nohynek L., Virkajarvi I., and Matto J. Stationary-phase acid and heat treatments for improvement of the viability of probiotic lactobacilli and bifidobacteria. J Appl Microbiol 96 (2004) 1205-1214
56. Saarela M., Virkajarvi I., Alakomi H.L., Mattila-Sandholm T., Vaari A., Suomalainen T., and Matto J. Influence of fermentation time, cryoprotectant and neutralization of cell concentrate on freeze-drying survival, storage stability, and acid and bile exposure of Bifidobacterium animalis ssp. lactis cells produced without milk-based ingredients. J Appl Microbiol 99 (2005) 1330-1339
57. Barrangou R., Altermann E., Hutkins R., Cano R., and Klaenhammer T.R. Functional and comparative genomic analyses of an operon involved in fructooligosaccharide utilization by Lactobacillus acidophilus. Proc Natl Acad Sci USA 100 (2003) 8957-8962
58. Ouwehand A.C., Derrien M.M.N., de Vos W.M., Tiihonen K., and Rautonen N. Prebiotics and other microbial substrates for gut functionality. Curr Opin Biotechnol 16 (2005) 212-217
59. Vaughan E.E., Heilig H.G., Ben-Amor K., and de Vos W.M. Diversity, vitality and activities of intestinal lactic acid bacteria and bifidobacteria assessed by molecular approaches. FEMS Microbiol Rev 29 (2005) 477-490
60. Vesa T., Pochart P., and Marteau P. Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract. Aliment Pharmacol Ther 14 (2000) 823-828
61. 15N-incorporation of double isotope labeled Lactobacillus johnsonii in humans. Eur J Clin Nutr 59 (2005) 1167-1172. The first study to address the fate and kinetics of a probiotic in humans using stable isotopes. Although the stable isotopes could be recovered from the breath of subjects after only 30 min, the orocecal transit time was 3.7 h. Remarkably, almost half of the label was recovered in urine (as expected notably the nitrogen) and faecal samples.
62. Marteau P., and Shanahan F. Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. Best Pract Res Clin Gastroenterol 17 (2003) 725-740
63. Bron P.A., Marco M., Hoffer S.M., Van Mullekom E., de Vos W.M., and Kleerebezem M. Genetic characterization of the bile salt response in Lactobacillus plantarum and analysis of responsive promoters in vitro and in situ in the gastrointestinal tract. J Bacteriol 186 (2004) 7829-7835
64. Bron PA, Marco M, Hoffer SM, Van Mullekom E, de Vos WM, Kleerebezem M: Global response of Lactobacillus plantarum to bile salts. J Appl Microbiol 2006, in press.
65. Di Caro S., Tao H., Grillo A., Elia C., Gasbarrini G., Sepulveda A.R., and Gasbarrini A. Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis 37 (2005) 320-329
66. Hanniffy S., Wiedermann U., Repa A., Mercenier A., Daniel C., Fioramonti J., Tlaskolova H., Kozakova H., Israelsen H., Madsen S., et al. Potential and opportunities for use of recombinant lactic acid bacteria in human health. Adv Appl Microbiol 56 (2004) 1-64
67. Seegers J.F. Lactobacilli as live vaccine delivery vectors: progress and prospects. Trends Biotechnol 20 (2002) 508-515
68. Steidler L. Delivery of therapeutic proteins to the mucosa using genetically modified microflora. Expert Opin Drug Deliv 2 (2005) 737-746
69. Steidler L., Neirynck S., Huyghebaert N., Snoeck V., Vermeire A., Goddeeris B., Cox E., Remon J.P., and Remaut E. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 21 (2003) 758-759
70. Bron P.A., Grangette C., Mercenier A., de Vos W.M., and Kleerebezem M. Identification of Lactobacillus plantarum genes that are induced in the gastrointestinal tract of mice. J Bacteriol 186 (2004) 5721-5729
71. Peltonen K., el-Nezami H., Haskard C., Ahokas J., and Salminen S. Aflatoxin B1 binding by dairy strains of lactic acid bacteria and bifidobacteria. J Dairy Sci 84 (2001) 2152-2156
72. Gratz S., Mykkanen H., and El-Nezami H. Aflatoxin B1 binding by a mixture of Lactobacillus and Propionibacterium: in vitro versus ex vivo. J Food Prot 68 (2005) 2470-2474
73. Meriluoto J., Gueimonde M., Haskard C.A., Spoof L., Sjovall O., and Salminen S. Removal of the cyanobacterial toxin microcystin-LR by human probiotics. Toxicon 46 (2005) 111-114. This and other papers from this group have addressed for the first time the use of probiotic LAB to detoxify foods. This concept has been expanded here to remove bacterial toxins associated with aquatic environments.
74. Famularo G., De Simone C., Pandev V., Sahu A.R., and Minisola G. Probiotic lactobacilli; an innovative tool to correct the malabsorption syndrome of vegetarians?. Med Hypotheses 65 (2005) 1132-1135